In one paragraphArticle in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Ana A WeilCenter for Emerging and Re-Emerging Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-6170-4306 Sarah M BakerCenter for Emerging and Re-Emerging Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-0177-8135 Frederick S BucknerCenter for Emerging and Re-Emerging Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
Geoffrey S GottliebCenter for Emerging and Re-Emerging Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
Kevin HybiskeCenter for Emerging and Re-Emerging Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-2967-3079 David M KoelleCenter for Emerging and Re-Emerging Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-1255-9023 Tara B ReidCenter for Emerging and Re-Emerging Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.
Michelle C SaboCenter for Emerging and Re-Emerging Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-5058-3166 Chetan SeshadriCenter for Emerging and Re-Emerging Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-2783-7540 Javeed A ShahCenter for Emerging and Re-Emerging Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-2997-7988 Wesley C Van VoorhisCenter for Emerging and Re-Emerging Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-6141-2015 Helen Y ChuCenter for Emerging and Re-Emerging Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.ORCID 0000-0001-8502-9600 Funding
Alex MacMillan FoundationCerusGileadHeiser FoundationPfizer
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
early-Stage investigatorNational Institutes of Healthphysician-scientiststudy section
Identifiers
PMID42535387
PMCPMC13600399
What OpenQuestion holds
Textmetadata
Read underepoch 390